Skip to main content
. 2021 Jan 20;9(1):e001765. doi: 10.1136/bmjdrc-2020-001765

Figure 5.

Figure 5

Major complications and mortality in the propensity score-matched SGLT2i ’add-on’ versus SGLT2i ’ switch’ cohorts. P values are derived from the Cox proportional hazards model. The number of patients at risk is different in the individual outcomes because patients were censored if they had that particular outcome in the previous 1 year. AMI, acute myocardial infarction; HHF, hospitalization for heart failure; PCI, percutaneous coronary intervention; SGLT2i, sodium-glucose cotransporter-2 inhibitor.